Joon Lee
Stock Analyst at Truist Securities
(4.71)
# 146
Out of 4,941 analysts
111
Total ratings
57.41%
Success rate
42.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $387.77 | +26.36% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $45.25 | +90.06% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $39.86 | +88.16% | 8 | Apr 28, 2025 | |
| ARVN Arvinas | Maintains: Buy | $65 → $21 | $6.80 | +209.05% | 6 | Apr 9, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $76 → $150 | $73.59 | +103.83% | 8 | Mar 31, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $90 → $50 | $10.86 | +360.41% | 4 | Mar 4, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $175 → $85 | $48.46 | +75.40% | 5 | Mar 3, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $190 → $200 | $105.23 | +90.06% | 5 | Feb 19, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $100 → $120 | $56.60 | +112.01% | 5 | Feb 12, 2025 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $18 | $3.70 | +386.49% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $660 → $700 | $637.40 | +9.82% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 → $57 | $105.19 | -45.81% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.04 | +164.90% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $8.45 | +326.04% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $20.34 | +76.99% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.29 | +249.34% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $11.50 | +47.83% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $118 → $90 | $56.86 | +58.28% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $2.47 | +1,519.43% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $113.33 | +76.48% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $2.91 | +71.82% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.39 | +430.97% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.40 | +11,566.67% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $20.09 | +69.24% | 1 | Mar 16, 2021 |
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $387.77
Upside: +26.36%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $45.25
Upside: +90.06%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $39.86
Upside: +88.16%
Arvinas
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $6.80
Upside: +209.05%
Corcept Therapeutics
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $73.59
Upside: +103.83%
Intellia Therapeutics
Mar 4, 2025
Maintains: Buy
Price Target: $90 → $50
Current: $10.86
Upside: +360.41%
Praxis Precision Medicines
Mar 3, 2025
Maintains: Buy
Price Target: $175 → $85
Current: $48.46
Upside: +75.40%
Axsome Therapeutics
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $105.23
Upside: +90.06%
CRISPR Therapeutics AG
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $56.60
Upside: +112.01%
Larimar Therapeutics
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.70
Upside: +386.49%
Jan 14, 2025
Reiterates: Buy
Price Target: $660 → $700
Current: $637.40
Upside: +9.82%
Jan 8, 2025
Reiterates: Buy
Price Target: $44 → $57
Current: $105.19
Upside: -45.81%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $6.04
Upside: +164.90%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $8.45
Upside: +326.04%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $20.34
Upside: +76.99%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.29
Upside: +249.34%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $11.50
Upside: +47.83%
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $56.86
Upside: +58.28%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $2.47
Upside: +1,519.43%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $113.33
Upside: +76.48%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $2.91
Upside: +71.82%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.39
Upside: +430.97%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.40
Upside: +11,566.67%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $20.09
Upside: +69.24%